C-reactive Protein-albumin-lymphocyte Index as a Novel Biomarker for Progression in Patients Undergoing Surgery for Renal Cancer
In addition to the existing risk factors for RCC recurrence, such as sarcomatoid features and Fuhrman grade, we propose that the CALLY index is a predictor of postoperative recurrence and that patients with a low CALLY index are good candidates for postoperative treatment. Our study may help select patients with pT3 disease with a high risk of recurrence who require postoperative treatment.
Authors
- Koji Shiraishi (ORCID: https://orcid.org/0000-0002-3278-7747)
- Kosuke Shimizu (ORCID: https://orcid.org/0000-0003-1159-5436)
- Hiroshi Hirata (ORCID: https://orcid.org/0000-0002-6906-1608)
- Nakanori Fujii
- Toshiya Hiroyoshi
- Keita Kobayashi
- Oka S (ORCID: https://orcid.org/0000-0002-5470-7365)
- Kimihiko Nakamura
- Naohito Isoyama
Institutions
- Yamaguchi University (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2024-11-02
- DOI
- https://doi.org/10.21873/cdp.10391
- Citations
- 9
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.77